journal article·2024-01-30Open access

HIV-1 Capsid Uncoating Is a Multistep Process That Proceeds through Defect Formation Followed by Disassembly of the Capsid Lattice

Levi B. Gifford, Gregory B. Melikyan

ACS Nano· Volume 18· Issue 4

Abstract

High Resolution Image Download MS PowerPoint Slide The HIV-1 core consists of a cone-shaped capsid shell made of capsid protein (CA) hexamers and pentamers encapsulating the viral genome. HIV-1 capsid disassembly, referred to as uncoating, is important for productive infection; however, the location, timing, and regulation of uncoating remain controversial. Here, we employ amber codon suppression to directly label CA. In addition, a fluid phase fluorescent probe is incorporated into the viral core to detect small defects in the capsid lattice. This double-labeling strategy enables the visualization of uncoating of single cores in vitro and in living cells, which we found to always proceed through at least two distinct steps─the formation of a defect in the capsid lattice that initiates gradual loss of CA below a detectable level. Importantly, intact cores containing the fluid phase and CA fluorescent markers enter and uncoat in the nucleus, as evidenced by a sequential loss of both markers, prior to establishing productive infection. This two-step uncoating process is observed in different cells, including a macrophage line. Notably, the lag between the release of fluid phase marker and terminal loss of CA appears to be independent of the cell type or reverse transcription and is much longer (>5-fold) for nuclear capsids compared to cell-free cores or cores in the cytosol, suggesting that the capsid lattice is stabilized by capsid-binding nuclear factors. Our results imply that intact HIV-1 cores enter the cell nucleus and that uncoating is initiated through a localized defect in the capsid lattice prior to a global loss of CA.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: HIV Research and Treatment · Bacteriophages and microbial interactions · Plant Virus Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia 30322, United States

Children’s Healthcare of Atlanta, Atlanta, Georgia 30322, United States

Funding

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

References (100+)

Show source-provided references
1. 10.1038/nrmicro350310.1038/nrmicro3503 ↗
2. 10.1186/s12977-021-00566-010.1186/s12977-021-00566-0 ↗
3. 10.1371/journal.ppat.101010910.1371/journal.ppat.1010109 ↗
4. 10.1016/j.jmb.2011.04.02110.1016/j.jmb.2011.04.021 ↗
5. 10.1016/j.crstbi.2020.10.00210.1016/j.crstbi.2020.10.002 ↗
6. 10.1038/s41467-020-17256-810.1038/s41467-020-17256-8 ↗
7. 10.1016/j.tim.2017.04.00410.1016/j.tim.2017.04.004 ↗
8. 10.3390/v1308142510.3390/v13081425 ↗
9. 10.1016/j.virusres.2012.09.01210.1016/j.virusres.2012.09.012 ↗
10. 10.1038/s41579-019-0225-210.1038/s41579-019-0225-2 ↗
11. 10.3390/v1011064010.3390/v10110640 ↗
12. 10.1038/s41564-021-00868-110.1038/s41564-021-00868-1 ↗
13. 10.1038/s41594-023-00925-910.1038/s41594-023-00925-9 ↗
14. 10.1128/JVI.02219-1410.1128/JVI.02219-14 ↗
15. 10.1128/JVI.00984-2010.1128/JVI.00984-20 ↗
16. 10.1186/s12977-016-0250-410.1186/s12977-016-0250-4 ↗
17. 10.1128/JVI.00706-1910.1128/JVI.00706-19 ↗
18. 10.1186/1742-4690-9-3010.1186/1742-4690-9-30 ↗
19. 10.1073/pnas.101452210810.1073/pnas.1014522108 ↗
20. 10.1128/JVI.01295-1010.1128/JVI.01295-10 ↗
21. 10.1128/JVI.00476-1510.1128/JVI.00476-15 ↗
22. 10.1186/s12977-016-0292-710.1186/s12977-016-0292-7 ↗
23. 10.1007/978-1-62703-670-2_310.1007/978-1-62703-670-2_3 ↗
24. 10.1073/pnas.170624511410.1073/pnas.1706245114 ↗
25. 10.1073/pnas.192063111710.1073/pnas.1920631117 ↗
26. 10.3390/v1211123410.3390/v12111234 ↗
27. 10.1073/pnas.201946711810.1073/pnas.2019467118 ↗
28. 10.1371/journal.ppat.100657010.1371/journal.ppat.1006570 ↗
29. 10.1016/j.chom.2018.08.00210.1016/j.chom.2018.08.002 ↗
30. 10.3390/v1005027510.3390/v10050275 ↗
31. 10.1128/mBio.02501-1910.1128/mBio.02501-19 ↗
32. 10.1128/JVI.01024-1910.1128/JVI.01024-19 ↗
33. 10.7554/eLife.6477610.7554/eLife.64776 ↗
34. 10.1128/mbio.01959-2210.1128/mbio.01959-22 ↗
35. 10.1186/1742-4690-10-7010.1186/1742-4690-10-70 ↗
36. 10.1038/s41564-020-0735-810.1038/s41564-020-0735-8 ↗
37. 10.1016/j.celrep.2020.10820110.1016/j.celrep.2020.108201 ↗
38. 10.1016/j.cell.2021.01.02510.1016/j.cell.2021.01.025 ↗
39. 10.1146/annurev-virology-020922-11092910.1146/annurev-virology-020922-110929 ↗
40. 10.1038/s41586-020-2670-510.1038/s41586-020-2670-5 ↗
41. 10.1016/j.celrep.2020.10820110.1016/j.celrep.2020.108201 ↗
42. 10.1128/JVI.00135-2010.1128/JVI.00135-20 ↗
43. 10.1371/journal.ppat.100948410.1371/journal.ppat.1009484 ↗
44. 10.1371/journal.ppat.101075410.1371/journal.ppat.1010754 ↗
45. 10.3389/fmicb.2021.65248610.3389/fmicb.2021.652486 ↗
46. 10.1371/journal.ppat.100346110.1371/journal.ppat.1003461 ↗
47. 10.1128/JVI.01088-0710.1128/JVI.01088-07 ↗
48. 10.7554/eLife.3477210.7554/eLife.34772 ↗
49. 10.1371/journal.ppat.100570910.1371/journal.ppat.1005709 ↗
50. 10.1371/journal.pone.001701610.1371/journal.pone.0017016 ↗
51. 10.1002/chem.20150164710.1002/chem.201501647 ↗
52. 10.1016/j.chembiol.2017.04.00710.1016/j.chembiol.2017.04.007 ↗
53. 10.1038/s41598-018-33115-510.1038/s41598-018-33115-5 ↗
54. 10.1038/s42003-019-0518-z10.1038/s42003-019-0518-z ↗
55. 10.1126/science.aaw264410.1126/science.aaw2644 ↗
56. 10.1038/s42003-019-0518-z10.1038/s42003-019-0518-z ↗
57. 10.1006/jmbi.1997.105110.1006/jmbi.1997.1051 ↗
58. 10.3390/biom907025510.3390/biom9070255 ↗
59. 10.1016/j.virol.2011.11.00310.1016/j.virol.2011.11.003 ↗
60. Ao, Y.; Grover, J. R.; Han, Y.; Zhong, G.; Qin, W.; Ghimire, D.; Haque, A.; Bhattacharjee, R.; Zhang, B.; Arthos, J.; Lemke, E. A.; Kwong, P. D.; Lu, M. An intact amber-free HIV-1 system for in-virus protein bioorthogonal click labeling that delineates envelope conformational dynamics. BioRxiv 2023. 2023.02.28.530526. 10.1101/2023.02.28.530526 (accessed on 01–17–2024).10.1101/2023.02.28.530526 ↗
61. 10.1038/nsmb78510.1038/nsmb785 ↗
62. 10.1101/cshperspect.a00692410.1101/cshperspect.a006924 ↗
63. 10.1126/sciadv.add743410.1126/sciadv.add7434 ↗
64. 10.3390/cancers1305094910.3390/cancers13050949 ↗
65. 10.1128/JVI.01741-1810.1128/JVI.01741-18 ↗
66. 10.1128/JVI.00476-1510.1128/JVI.00476-15 ↗
67. 10.1128/JVI.00845-1810.1128/JVI.00845-18 ↗
68. 10.1038/ncomms1071410.1038/ncomms10714 ↗
69. 10.1089/aid.2014.036110.1089/aid.2014.0361 ↗
70. 10.1186/s12977-019-0471-410.1186/s12977-019-0471-4 ↗
71. 10.1128/JVI.00458-1610.1128/JVI.00458-16 ↗
72. 10.7554/eLife.1626910.7554/eLife.16269 ↗
73. 10.1038/s41579-019-0225-210.1038/s41579-019-0225-2 ↗
74. 10.1186/s12985-020-01301-510.1186/s12985-020-01301-5 ↗
75. 10.1016/j.chom.2019.07.00710.1016/j.chom.2019.07.007 ↗
76. 10.3390/v1303038610.3390/v13030386 ↗
77. 10.1128/JVI.00984-2010.1128/JVI.00984-20 ↗
78. 10.21769/BioProtoc.329710.21769/BioProtoc.3297 ↗
79. 10.1128/JVI.78.19.10803-10813.200410.1128/JVI.78.19.10803-10813.2004 ↗
80. 10.1038/nbt1096-124610.1038/nbt1096-1246 ↗
81. 10.1186/s12977-021-00583-z10.1186/s12977-021-00583-z ↗
82. 10.1126/sciadv.abe471610.1126/sciadv.abe4716 ↗
83. 10.1128/JVI.73.3.2343-2349.199910.1128/JVI.73.3.2343-2349.1999 ↗
84. 10.1002/0471140864.ps3001s7310.1002/0471140864.ps3001s73 ↗
85. 10.1083/jcb.20140206610.1083/jcb.201402066 ↗
86. 10.1126/science.abc842010.1126/science.abc8420 ↗
87. 10.1128/JVI.00289-1710.1128/JVI.00289-17 ↗
88. 10.1038/nature1011710.1038/nature10117 ↗
89. 10.1016/j.virol.2016.05.00210.1016/j.virol.2016.05.002 ↗
90. 10.3390/v1303039510.3390/v13030395 ↗
91. 10.1016/j.jmb.2010.06.04210.1016/j.jmb.2010.06.042 ↗
92. 10.1126/science.aaa593610.1126/science.aaa5936 ↗
93. 10.1128/JVI.00166-2110.1128/JVI.00166-21 ↗
94. 10.1073/pnas.211778111910.1073/pnas.2117781119 ↗
95. Faysal, K. M. R.; Walsh, J.; Renner, N.; Márquez, C. L.; Shah, V. B.; Tuckwell, A. J.; Christie, M. P.; Parker, M. W.; Turville, S. G.; Towers, G. J.; James, L.; Jacques, D. A.; Böcking, T. Pharmacologic hyperstabilisation of the HIV-1 capsid lattice induces capsid failure. BioRxiv 2022. 2022.09.21.508807. 10.1101/2022.09.21.508807 (accessed on 01–17–2024).10.1101/2022.09.21.508807 ↗
96. 10.1016/j.chom.2018.03.00910.1016/j.chom.2018.03.009 ↗
97. 10.1016/j.molcel.2022.06.01010.1016/j.molcel.2022.06.010 ↗
98. 10.1128/JVI.76.11.5667-5677.200210.1128/JVI.76.11.5667-5677.2002 ↗
99. 10.1128/JVI.72.4.2855-2864.199810.1128/JVI.72.4.2855-2864.1998 ↗
100. 10.1172/JCI3935410.1172/JCI39354 ↗